Skip to main content
. 2021 Jan 5;25(3):1827–1838. doi: 10.1007/s11030-020-10166-3

Fig. 2.

Fig. 2

Structures of some potent SARS-CoV-2 Mpro inhibitors containing good fragments highlighted in deep blue color